{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T06:24:35Z","timestamp":1746339875954},"reference-count":15,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2010,9,1]],"date-time":"2010-09-01T00:00:00Z","timestamp":1283299200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,7,16]],"date-time":"2013-07-16T00:00:00Z","timestamp":1373932800000},"content-version":"vor","delay-in-days":1049,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Journal of Infectious Diseases"],"published-print":{"date-parts":[[2010,9]]},"DOI":"10.1016\/j.ijid.2009.07.023","type":"journal-article","created":{"date-parts":[[2009,12,17]],"date-time":"2009-12-17T09:23:25Z","timestamp":1261041805000},"page":"e227-e229","source":"Crossref","is-referenced-by-count":7,"special_numbering":"S3","title":["Treatment of vancomycin-intermediate Staphylococcus aureus (VISA) endocarditis with linezolid"],"prefix":"10.1016","volume":"14","author":[{"given":"Abdullah","family":"Balkhair","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zakariya Al","family":"Muharrmi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laila","family":"Darwish","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hatem","family":"Farhan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mansour","family":"Sallam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijid.2009.07.023_bib1","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1016\/S0140-6736(97)07324-8","article-title":"Dissemination in Japanese hospitals of strains of Staphylococcus aureus heterogeneously resistant to vancomycin","volume":"350","author":"Hiramatsu","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.ijid.2009.07.023_bib2","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1093\/jac\/40.1.135","article-title":"Methicillin- resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility","volume":"40","author":"Hiramatsu","year":"1997","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijid.2009.07.023_bib3","first-page":"624","article-title":"Reduced susceptibility of Staphylococcus aureus to vancomycin\u2014Japan, 1996","volume":"46","year":"1997","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"Suppl 4","key":"10.1016\/j.ijid.2009.07.023_bib4","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1046\/j.1469-0691.2001.00054.x","article-title":"The VISA\/GISA problem: therapeutic implications","volume":"7","author":"Li\u00f1ares","year":"2001","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.ijid.2009.07.023_bib5","doi-asserted-by":"crossref","first-page":"E105","DOI":"10.1016\/j.ajic.2007.04.120","article-title":"Vancomycin-intermediate Staphylococcus aureus (VISA) scare: an opportunity to put infection control (IC) processes to the test","volume":"35","author":"Shaikh","year":"2007","journal-title":"Am J Infect Control"},{"key":"10.1016\/j.ijid.2009.07.023_bib6","unstructured":"Clinical and Laboratory Standards Institute (CLSI). Performance standards for antimicrobial susceptibility testing. CLSI approved standard M100-S15. Wayne, PA: CLSI; 2005."},{"key":"10.1016\/j.ijid.2009.07.023_bib7","unstructured":"Clinical and Laboratory Standards Institute (CLSI). Performance standards for antimicrobial susceptibility testing. Sixteenth informational supplement. CLSI document M100-S16. Wayne, PA: CLSI; 2006."},{"key":"10.1016\/j.ijid.2009.07.023_bib8","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1128\/AAC.50.2.428-438.2006","article-title":"Novel mechanism of antibiotic resistance originating in vancomycin-intermediate Staphylococcus aureus","volume":"50","author":"Cui","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijid.2009.07.023_bib9","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1086\/491709","article-title":"Vancomycin: a history","volume":"42","author":"Levine","year":"2006","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijid.2009.07.023_bib10","unstructured":"Centers for Disease Control and Prevention. Laboratory detection of vancomycin-intermediate\/resistant Staphylococcus aureus (VISA\/VRSA). Updated: April 2006, http:\/\/www.cdc.gov\/ncidod\/dhqp\/ar_visavrsa_labFAQ.html. Accessed Dec 1st 2009-12-01."},{"key":"10.1016\/j.ijid.2009.07.023_bib11","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1086\/317542","article-title":"Vancomycin-intermediate and resistant Staphylococcus aureus: what the infectious disease specialist needs to know","volume":"32","author":"Weinstein","year":"2001","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijid.2009.07.023_bib12","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1086\/513203","article-title":"The rationale for revising the Clinical and Laboratory Standards Institute vancomycin minimal inhibitory concentration interpretive criteria for Staphylococcus aureus","volume":"44","author":"Tenover","year":"2007","journal-title":"Clin Infect Dis"},{"issue":"Suppl 4","key":"10.1016\/j.ijid.2009.07.023_bib13","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1046\/j.1469-0691.2001.00061.x","article-title":"Linezolid: pharmacokinetic characteristics and clinical studies","volume":"7","author":"Bouza","year":"2001","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.ijid.2009.07.023_bib14","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S0140-6736(01)05410-1","article-title":"Linezolid resistance in a clinical isolate of Staphylococcus aureus","volume":"358(9277)","author":"Tsiodras","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.ijid.2009.07.023_bib15","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1111\/j.1469-0691.2006.01585.x","article-title":"Linezolid therapy for infective endocarditis","volume":"13","author":"Mu\u00f1oz","year":"2007","journal-title":"Clin Microbiol Infect"}],"container-title":["International Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971209003373?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971209003373?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,14]],"date-time":"2018-12-14T08:25:52Z","timestamp":1544775952000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1201971209003373"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,9]]},"references-count":15,"alternative-id":["S1201971209003373"],"URL":"https:\/\/doi.org\/10.1016\/j.ijid.2009.07.023","relation":{},"ISSN":["1201-9712"],"issn-type":[{"value":"1201-9712","type":"print"}],"subject":[],"published":{"date-parts":[[2010,9]]}}}